Clinical Trial Update: Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke [NA]

View source ↗

Summary

A clinical trial evaluating the Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for acute hemorrhagic stroke has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke

Drugs mentioned

• Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Hemorrhagic Stroke | NA | Status: SUSPENDED